Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jul 2026 for Olema Pharmaceuticals, Inc., €129k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Harmon Cyrus: trading record in brief
This profile gathers the share dealings of Harmon Cyrus in Olema Pharmaceuticals, Inc. Between 23 July 2026 and 24 July 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 24 July 2026, the filings show a transaction worth €129k in Olema Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Harmon Cyrus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
12,500 shares@ US$11.7136CommonSEC144:0001959173-26-005357
12,500 shares@ US$11.5790.014% mcap2.8% of flowCommonSEC144:0001959173-26-005343
2 of 2 declarations
